2-aminomethylenecyclohexanone | 17425-57-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 乙烯基酰胺
• 英文名称: 2-aminomethylenecyclohexanone
• 英文别名: 2-seqcis-Aminomethylen-cyclohexanon-(1)；2-Aminomethylen-cyclohexan-1-on；(2Z)-2-(aminomethylidene)cyclohexan-1-one
• CAS: 17425-57-9
• 化学式: C₇H₁₁NO
• 分子量: 125.17
• InChiKey: OHPIUROCJFAIGC-WAYWQWQTSA-N

物化性质

• 熔点：
  110 °C
• 沸点：
  231.1±29.0 °C(Predicted)
• 密度：
  1.166±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-aminomethylenecyclohexanone 在 palladium on activated charcoal ammonium acetate 、 氢气 作用下， 以 溶剂黄146 为溶剂， 反应 24.0h， 生成 1,2,3,4,6,7,8,9-octahydro-benzo[b][1,6]-naphthyridine
  参考文献：
  名称：

  抗眩晕剂。三，5,6,7,8-四氢-1,6-萘啶甲基同系物的合成。

  摘要：

  5-甲基-(4a)、7-甲基-(4b)和8-甲基-5, 6, 7, 8-四氢-1, 6-萘啶 (4c) 通过对吡啶衍生物的化学修饰合成而成。另一方面，通过将1-苄基-4-哌啶酮与相应的3-氨基-烯酮缩合后去苄基化，合成了具有5, 6, 7, 8-四氢-1, 6-萘啶芳环中甲基取代基的化合物(20b, c)。缩合反应的路径进行了简要讨论。

  DOI：

  10.1248/cpb.32.2522

文献信息

• Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof
  申请人：Petasis Nicos A.

  公开号：US20090247766A1

  公开（公告）日：2009-10-01

  The invention relates to a nitrogen heterocycle compound of formula 1: Also disclosed are a method of synthesizing the compound and use of the compound for treating various diseases and conditions.

  该发明涉及一种化学式为1的氮杂环化合物。还公开了一种合成该化合物的方法，以及利用该化合物治疗各种疾病和病况的用途。
• USE OF DIBENZOFURANONE DERIVATIVES TO INHIBIT KINASES
  申请人：Jose Joachim

  公开号：US20130225674A1

  公开（公告）日：2013-08-29

  The invention relates to a pharmaceutical product comprising a dibenzofuranone derivative as the active ingredient. The invention further relates to the use of dibenzofuranone derivatives to inhibit kinases, in particular serine/threonine kinases, to the use of dibenzofuranone derivatives for producing drugs and/or medicinal products for treatment, and to the use of dibenzofuranone derivatives as a diagnostic product for analyzing the role of protein kinases, in particular serine/threonine kinases, in particular protein kinase CK2 in cellular processes, the pathogenesis of diseases, ontogenesis and/or other developmental biological phenomena or relationships.
• US9303005B2
  申请人：——

  公开号：US9303005B2

  公开（公告）日：2016-04-05
• [EN] SUBSTITUTED NITROGEN HETEROCYCLES AND SYNTHESIS AND USES THEREOF<br/>[FR] HÉTÉROCYCLES D'AZOTE SUBSTITUÉS, LEUR SYNTHÈSE ET LEURS UTILISATIONS
  申请人：UNIV SOUTHERN CALIFORNIA

  公开号：WO2009121033A2

  公开（公告）日：2009-10-01

  The invention relates to a nitrogen heterocycle compound of formula (1) Also disclosed are a method of synthesizing the compound and use of the compound for treating various diseases and conditions.
• Antivertigo agents. III. Synthesis of 5,6,7,8-tetrahydro-1,6-naphthyridine methyl homologs.
  作者：AKIRA SHIOZAWA、YUHICHIRO ICHIKAWA、CHIKARA KOMURO、SHUJI KURASHIGE、HIROSHI MIYAZAKI、HIROSHI YAMANAKA、TAKAO SAKAMOTO

  DOI：10.1248/cpb.32.2522

  日期：——

  5-Methyl-(4a), 7-methyl-(4b), and 8-methyl-5, 6, 7, 8-tetrahydro-1, 6-naphthyridine (4c) were synthesized by chemical modification of pyridine derivatives. On the other hand, the synthesis of the compounds (20b, c) having a methyl group in the aromatic ring of 5, 6, 7, 8-tetrahydro-1, 6-naphthyridine was accomplished by the condensation of 1-benzyl-4-piperidinone with the corresponding 3-amino-enones followed by debenzylation. The pathway of the condensation is briefly discussed.

  5-甲基-(4a)、7-甲基-(4b)和8-甲基-5, 6, 7, 8-四氢-1, 6-萘啶 (4c) 通过对吡啶衍生物的化学修饰合成而成。另一方面，通过将1-苄基-4-哌啶酮与相应的3-氨基-烯酮缩合后去苄基化，合成了具有5, 6, 7, 8-四氢-1, 6-萘啶芳环中甲基取代基的化合物(20b, c)。缩合反应的路径进行了简要讨论。